• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌腋窝清扫术后手臂肿胀的发生率。

Incidence of arm swelling following axillary clearance for breast cancer.

作者信息

Hoe A L, Iven D, Royle G T, Taylor I

机构信息

University Surgical Unit, Royal South Hampshire Hospital, Southampton, UK.

出版信息

Br J Surg. 1992 Mar;79(3):261-2. doi: 10.1002/bjs.1800790326.

DOI:10.1002/bjs.1800790326
PMID:1555097
Abstract

Arm swelling was measured using volume determination in 118 patients following mastectomy (n = 60) or wide excision (n = 58), both with axillary clearance. The mean age was 60.5 years and the median follow-up was 22.5 months. Axillary clearance removed level III nodes. Axillary irradiation was given to only three patients with extensive (more than 75 per cent) nodal involvement. The incidence of early postoperative complications was 18.6 per cent. The incidence of lymphoedema was 7.6 per cent (nine patients). Three of these patients had early lymphoedema within 6 months of treatment. Arm circumference differences correlated poorly with volume differences. The incidence of lymphoedema following axillary clearance is low and comparable to that for sampling or no axillary surgery.

摘要

在118例接受乳房切除术(n = 60)或广泛切除术(n = 58)且均进行腋窝清扫的患者中,通过体积测定法测量手臂肿胀情况。平均年龄为60.5岁,中位随访时间为22.5个月。腋窝清扫清除了Ⅲ级淋巴结。仅3例有广泛(超过75%)淋巴结受累的患者接受了腋窝放疗。术后早期并发症的发生率为18.6%。淋巴水肿的发生率为7.6%(9例患者)。其中3例患者在治疗后6个月内出现早期淋巴水肿。手臂周长差异与体积差异的相关性较差。腋窝清扫后淋巴水肿的发生率较低,与取样或未进行腋窝手术的情况相当。

相似文献

1
Incidence of arm swelling following axillary clearance for breast cancer.乳腺癌腋窝清扫术后手臂肿胀的发生率。
Br J Surg. 1992 Mar;79(3):261-2. doi: 10.1002/bjs.1800790326.
2
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
3
Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.腋窝淋巴结清扫术与前哨淋巴结技术的比较发病率:对乳腺癌患者的影响。
Ann Surg. 2004 Jul;240(1):1-6. doi: 10.1097/01.sla.0000129358.80798.62.
4
An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle.对未切断胸小肌的预防性Ⅰ/Ⅱ级腋窝清扫术后手臂淋巴水肿发生率的审计。
Ann R Coll Surg Engl. 2003 May;85(3):158-61. doi: 10.1308/003588403321661299.
5
Prospective evaluation of the morbidity of axillary clearance for breast cancer.乳腺癌腋窝清扫术发病率的前瞻性评估
Br J Surg. 2001 Jan;88(1):114-7. doi: 10.1046/j.1365-2168.2001.01620.x.
6
Risk of lymphoedema following the treatment of breast cancer.乳腺癌治疗后发生淋巴水肿的风险。
Br J Surg. 1986 Jul;73(7):580-4. doi: 10.1002/bjs.1800730723.
7
Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.自我感知的而非客观存在的淋巴水肿与乳腺癌手术后长期健康相关生活质量的下降有关。
Eur J Surg Oncol. 2015 Apr;41(4):577-84. doi: 10.1016/j.ejso.2014.12.006. Epub 2015 Jan 13.
8
Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.肥胖是乳腺癌患者术后发生淋巴水肿的一个风险因素。
Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.
9
Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?腋窝反向绘图能否避免淋巴结阳性乳腺癌患者的淋巴水肿?
Eur J Surg Oncol. 2013 Aug;39(8):880-6. doi: 10.1016/j.ejso.2013.05.009. Epub 2013 Jun 2.
10
Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.乳腺癌女性淋巴水肿的危险因素:一项大型前瞻性队列研究。
Breast. 2016 Aug;28:29-36. doi: 10.1016/j.breast.2016.04.011. Epub 2016 May 13.

引用本文的文献

1
Analysis of Spinal Dysfunction in Breast Cancer Survivors with Lymphedema.乳腺癌伴淋巴水肿幸存者的脊柱功能障碍分析。
Asian Pac J Cancer Prev. 2021 Jun 1;22(6):1869-1873. doi: 10.31557/APJCP.2021.22.6.1869.
2
Moxibustion as a Therapy for Breast Cancer-Related Lymphedema in Female Adults: A Preliminary Randomized Controlled Trial.艾灸治疗女性乳腺癌相关上肢淋巴水肿的初步随机对照试验。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419866919. doi: 10.1177/1534735419866919.
3
[Not Available].[无可用内容]。
Arch Gynecol Obstet. 1995 Dec;256(Suppl 1):S85-S92. doi: 10.1007/BF02201942.
4
Unilateral upper extremity lymphedema deteriorates the postural stability in breast cancer survivors.单侧上肢淋巴水肿会使乳腺癌幸存者的姿势稳定性恶化。
Contemp Oncol (Pozn). 2014;18(4):279-84. doi: 10.5114/wo.2014.44120. Epub 2014 Jul 22.
5
Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.使用亚甲蓝染料和放射性硫胶体进行早期乳腺癌前哨淋巴结活检——一家印度机构的经验
Indian J Surg. 2008 Jun;70(3):111-9. doi: 10.1007/s12262-008-0033-9. Epub 2008 Jul 24.
6
Lymphatic complications in surgery: possibility of prevention and therapeutic options.淋巴系统并发症的外科处理:预防的可能性和治疗选择。
Updates Surg. 2012 Sep;64(3):211-6. doi: 10.1007/s13304-012-0165-0. Epub 2012 Jul 21.
7
Study of incidence of lymphedema in Indian patients undergoing axillary dissection for breast cancer.印度乳腺癌患者腋窝淋巴结清扫术后淋巴水肿发生率的研究。
Indian J Surg Oncol. 2010 Sep;1(3):263-9. doi: 10.1007/s13193-011-0046-x. Epub 2011 Mar 4.
8
Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.乳腺癌手术后仅行前哨淋巴结活检(SLN)与行SLN及腋窝淋巴结清扫术的发病率比较:一项针对659例患者的瑞士前瞻性多中心研究。
Ann Surg. 2007 Mar;245(3):452-61. doi: 10.1097/01.sla.0000245472.47748.ec.
9
Low-level laser therapy in management of postmastectomy lymphedema.低强度激光疗法在乳腺癌改良根治术后淋巴水肿治疗中的应用
Lasers Med Sci. 2006 Jul;21(2):90-4. doi: 10.1007/s10103-006-0380-3. Epub 2006 May 4.
10
Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.黑色素瘤腋窝淋巴结完全清扫术后的淋巴水肿:采用新的客观定义进行评估
Ann Surg. 2004 Nov;240(5):866-74. doi: 10.1097/01.sla.0000143271.32568.2b.